Evidence map›Paper›PMID 30973948›Full record

ArticlePloS one2019

Evaluation of standard pyrethroid based LNs (MiraNet and MagNet) in experimental huts against pyrethroid resistant Anopheles gambiae s.l. M'bé, Côte d'Ivoire: Potential for impact on vectorial capacity.

Welbeck A Oumbouke, Alphonsine A Koffi, Ludovic P Ahoua Alou, Mark Rowland, Raphael N'Guessan

Open access · goldAbstract readEvaluation Study
In one paragraph

Article in PloS one, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 1 pooled it
2.4field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 1 synthesis or guideline pooled it, 16 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. High efficacy of chlorfenapyr-based net InterceptorInfectious diseases of poverty · 2023
    Article
  6. Article
  7. Evaluation of YaheParasites & vectors · 2021
    Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

Welbeck A OumboukeDepartment of Disease Control, London School of Hygiene and Tropical Medicine, London, United Kingdom.ORCID 0000-0002-7254-7860
Alphonsine A KoffiInstitut Pierre Richet (IPR) / Institut National de Santé Publique (INSP), Bouaké, Côte d'Ivoire.
Ludovic P Ahoua AlouInstitut Pierre Richet (IPR) / Institut National de Santé Publique (INSP), Bouaké, Côte d'Ivoire.
Mark RowlandDepartment of Disease Control, London School of Hygiene and Tropical Medicine, London, United Kingdom.
Raphael N'GuessanDepartment of Disease Control, London School of Hygiene and Tropical Medicine, London, United Kingdom.
London School of Hygiene & Tropical Medicine · GBInstitut National de Santé Publique · CI

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThere is evidence from experimental hut and household studies that the entomological efficacy of long lasting pyrethroid treated nets (LLINs) is compromised in areas of pyrethroid resistance. The rapid increase in resistance intensity in African malaria vectors could further undermine the performance of these nets. The pyrethroid resistance intensity in Anopheles gambiae s.l. M'bé from central Côte d'Ivoire is reported to be high (> 1700 fold). Whether this translates into an increase in entomological indicators of malaria transmission needs investigation.

methodThe efficacy of two long lasting insecticidal nets (LN) MiraNet and MagNet, both alpha-cypermethrin based was evaluated in experimental huts against pyrethroid resistant Anopheles gambiae in M'bé, central Côte d'Ivoire. All nets were deliberately holed to simulate wear-and-tear and were tested unwashed and after 20 standardized washes.

resultsThe entry rates of An. gambiae s.l. into huts with insecticide treated nets were 62-84% lower than entry into huts with untreated nets (p < 0.001). Exit rates of An. gambiae s.l. with unwashed MiraNet and MagNet LNs were significantly greater than with untreated nets (50-60% vs 26%) and this effect after washing 20 times nets did not decrease. Blood-feeding with both nets was significantly inhibited relative to the untreated reference net (31-55%) (p < 0.001). Washing MiraNet LN 20 times had no significant impact on protection against An. gambiae s.l. bites but it did cause a significant fall by 40% in protection with MagNet LN (p < 0.001). All insecticide treated nets induced higher mortality of An. gambiae s.l. than the untreated net (p < 0.05). The impact though significant was limited (14-30%). The personal protection against An. gambiae s.l. bites derived from all treatments was high (75-90%). The overall insecticidal effect was compromised by pyrethroid resistance and was not detectable in some treatments.

conclusionIn this area of high pyrethroid resistance intensity (over 1700 fold), both MiraNet and MagNet LNs still conferred appreciable personal protection against mosquito bites despite inducing only slightly greater mortality of pyrethroid resistant Anopheles mosquitoes than untreated nets. The impact is comparable to moderately intense Benin resistance area (207 fold) and Burkina Faso (over 1000 fold). This preserved level of protection plus the small but sensitive killing of mosquitoes may continue to impact vectorial capacity despite high intensity of resistance. Nevertheless, there is an obvious need for strategies and nets with novel mode of action to enhance vector control.

Indexed as

Insecticide ResistanceMosquito VectorsAnimalsAnophelesCote d'IvoireFemaleHousingHumansInsecticidesInsecticide-Treated BednetsMalariaMosquito ControlPyrethrinscypermethrinInsecticidesPyrethrins

Identifiers

PMID30973948
PMCPMC6459542
OpenAlexW2937616091

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.